Related Articles
IL‑33/ST2 promotes the malignant progression of gastric cancer via the MAPK pathway
IL‑33 enhances glioma cell migration and invasion by upregulation of MMP2 and MMP9 via the ST2-NF-κB pathway
IL‑33 and kidney disease (Review)
Excessive activation of IL‑33/ST2 in cancer‑associated fibroblasts promotes invasion and metastasis in ovarian cancer
Increased soluble ST2 and IL‑4 serum levels are associated with disease severity in patients with membranous nephropathy